A Study Assessing the Safety and Effectiveness of Avena Sativa (Oat) Skincare Products for Skin Dryness and Itching in Cancer Patients

Full Title

A Single Center, Clinical Study to Determine the Safety and Efficacy of an Avena Sativa Skincare Regimen for Therapy-Related Pruritus and Xerosis in Cancer Patients

Purpose

Some treatments for cancer cause dry or itchy skin. In this study, researchers are evaluating the safety and effectiveness of an investigational skincare regimen (using an oat-based body wash, body cream, and anti-itch balm) for patients with dry and/or itchy skin caused by anticancer therapy. The products contain an ingredient called Avena sativa kernel, an oat flour known to soothe and protect the skin.

Participants will have their skin photographed to see how it is responding to the skincare products. They will also complete questionnaires about their skin condition during the study.

Eligibility

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must be receiving cancer treatments commonly known to cause mild to moderate skin reactions, such as skin rash, dryness, and/or itching.
  • Patients must be experiencing mild to moderate dry or itchy skin when they enroll in the study.
  • Patients may not be receiving radiation therapy or chemotherapies which cause moderate to severe skin reactions.
  • This study is for English-speaking patients age 18-65.

For more information about this study and to inquire about eligibility, please contact Dr. Mario E. Lacouture at 646-888-6014.

Protocol

19-152

Investigator

Co-Investigators

Diseases